UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.1.b.027 Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia

European neuropsychopharmacology, 2015-09, Vol.25, p.S193-S193

2015

Volltextzugriff (PDF)

P.4.004 Early onset of lithium prophylaxis as possible good prognostic factor for staging bipolar disorder

European neuropsychopharmacology, 2013-03, Vol.23, p.S71-S71

2013

Volltextzugriff (PDF)

P.3.b.034 Interaction of EAAT2 genotype and clozapine on cognitive remediation outcome

European neuropsychopharmacology, 2014-10, Vol.24, p.S511-S511

2014

Volltextzugriff (PDF)

P.2.d.011 Fronto–limbic disconnection in bipolar disorder

European neuropsychopharmacology, 2014-10, Vol.24, p.S419-S419

2014

Volltextzugriff (PDF)

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3‐β activity

Genes, brain and behavior, 2010-06, Vol.9 (4), p.365-371

2010

Volltextzugriff (PDF)

S.09.02 Predicting cognitive remediation outcome with genes

European neuropsychopharmacology, 2012-10, Vol.22, p.S125-S126

2012

Volltextzugriff (PDF)

P.3.b.021 Interleukin-1β, cognition and metabolic syndrome in schizophrenia

European neuropsychopharmacology, 2015-09, Vol.25, p.S475-S476

2015

Volltextzugriff (PDF)

Response to SSRIs and role of the hormonal therapy in post-menopausal depression

European neuropsychopharmacology, 2007-05, Vol.17 (6), p.400-405

2007

Volltextzugriff (PDF)

Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study

Neuropsychological rehabilitation, 2010-10, Vol.20 (5), p.659-674

2010

Volltextzugriff (PDF)

P.4.013 Fronto-limbic disconnection in bipolar disorder

European neuropsychopharmacology, 2014-03, Vol.24, p.S90-S90

2014

Volltextzugriff (PDF)

P.4.006 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study

European neuropsychopharmacology, 2014-03, Vol.24, p.S85-S86

2014

Volltextzugriff (PDF)

P.3.f.023 Effect of COMT functional polymorphism on bias against disconfirmatory evidence in schizophrenia

European neuropsychopharmacology, 2013-10, Vol.23, p.S505-S505

2013

Volltextzugriff (PDF)

P.3.b.013 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study

European neuropsychopharmacology, 2014-10, Vol.24, p.S498-S499

2014

Volltextzugriff (PDF)

S.07.08 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study

European neuropsychopharmacology, 2014-10, Vol.24, p.S120-S120

2014

Volltextzugriff (PDF)

Serotonin transporter gene (5-HTTLPR) and major psychoses

Molecular psychiatry, 2002, Vol.7 (1), p.95-99

2002

Volltextzugriff (PDF)

A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders

Molecular psychiatry, 1996-12, Vol.1 (6), p.453

1996

Volltextzugriff (PDF)

Morbidity Risk for Obsessive-Compulsive Spectrum Disorders in First-Degree Relatives of Patients With Eating Disorders

The American journal of psychiatry, 2001-04, Vol.158 (4), p.563-569

2001

Volltextzugriff (PDF)

P.3.b.029 Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms

European neuropsychopharmacology, 2013-10, Vol.23, p.S446-S446

2013

Volltextzugriff (PDF)

P.1.e.020 Caudate grey matter volume in obsessivecompulsive disorder is influenced by adverse childhood experiences and ongoing drug treatment

European neuropsychopharmacology, 2011, Vol.21, p.S314-S315

2011

Volltextzugriff (PDF)

P.6.a.012 Effects of transcranial neuromagnetic and neuroelectical stimulation on alcohol craving

European neuropsychopharmacology, 2011, Vol.21, p.S565-S566

2011

Volltextzugriff (PDF)

P.1.g.010 Exploring effects of EAATs polymorphisms on cognitive functions in schizophrenia

European neuropsychopharmacology, 2012-10, Vol.22, p.S210-S210

2012

Volltextzugriff (PDF)

P.3.a.009 Effects of the interaction between adducins and EAAT2 polymorphisms on cognition in schizophrenia: preliminary findings

European neuropsychopharmacology, 2012-10, Vol.22, p.S308-S309

2012

Volltextzugriff (PDF)

P.3.a.014 Exploring the effect of genetic variability of adducins on cognition in schizophrenia

European neuropsychopharmacology, 2012-10, Vol.22, p.S311-S312

2012

Volltextzugriff (PDF)

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment

British journal of psychiatry, 1995-02, Vol.166 (2), p.244-250

1995

Volltextzugriff (PDF)

P.3.a.016 Effects of catechol-O-methyltransferase Val108/158Met and Saitohin q7r polymorphisms on cognitive functions in schizophrenia

European neuropsychopharmacology, 2011, Vol.21, p.S462-S462

2011

Volltextzugriff (PDF)

26 – 50 von 506

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(457)
Mit Volltextzugriff
(382)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(285)
Science & Technology
(283)
Life Sciences & Biomedicine
(275)
Psychiatry
(244)
Male
(234)
Female
(232)
Adult
(196)
Biological And Medical Sciences
(181)
Medical Sciences
(175)
Middle Aged
(168)
Psychology. Psychoanalysis. Psychiatry
(161)
Psychopathology. Psychiatry
(115)
Neurosciences & Neurology
(97)
Adult And Adolescent Clinical Studies
(91)
Bipolar Disorder
(67)
Neurosciences
(66)
Mood Disorders
(63)
Internal Medicine
(59)
Pharmacology. Drug Treatments
(57)
Pharmacology & Pharmacy
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

P.1.b.027 Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia

P.4.004 Early onset of lithium prophylaxis as possible good prognostic factor for staging bipolar disorder

P.3.b.034 Interaction of EAAT2 genotype and clozapine on cognitive remediation outcome

P.2.d.011 Fronto–limbic disconnection in bipolar disorder

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3‐β activity

S.09.02 Predicting cognitive remediation outcome with genes

P.3.b.021 Interleukin-1β, cognition and metabolic syndrome in schizophrenia

Response to SSRIs and role of the hormonal therapy in post-menopausal depression

Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study

P.4.013 Fronto-limbic disconnection in bipolar disorder

P.4.006 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study

P.3.f.023 Effect of COMT functional polymorphism on bias against disconfirmatory evidence in schizophrenia

P.3.b.013 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study

S.07.08 Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study

Serotonin transporter gene (5-HTTLPR) and major psychoses

A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders

Morbidity Risk for Obsessive-Compulsive Spectrum Disorders in First-Degree Relatives of Patients With Eating Disorders

P.3.b.029 Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms

P.1.e.020 Caudate grey matter volume in obsessivecompulsive disorder is influenced by adverse childhood experiences and ongoing drug treatment

P.6.a.012 Effects of transcranial neuromagnetic and neuroelectical stimulation on alcohol craving

P.1.g.010 Exploring effects of EAATs polymorphisms on cognitive functions in schizophrenia

P.3.a.009 Effects of the interaction between adducins and EAAT2 polymorphisms on cognition in schizophrenia: preliminary findings

P.3.a.014 Exploring the effect of genetic variability of adducins on cognition in schizophrenia

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment

P.3.a.016 Effects of catechol-O-methyltransferase Val108/158Met and Saitohin q7r polymorphisms on cognitive functions in schizophrenia

Suchergebnisse filtern